Analysis of clinical characteristics and risk factors for digestive system manifestations in rheumatic diseases
Abstract
Introduction/Objective. The objective of the paper was to explore the risk factors and prediction models of digestive system complications in patients with rheumatic diseases. Methods. This case-control retrospective study enrolled 326 patients with rheumatic diseases (163 with digestive system involvement and 163 without), collecting demographic data, laboratory parameters (liver enzymes, lipid profiles, etc.), and disease types (rheumatoid arthritis, connective tissue diseases, gout, etc.). Potential variables were screened through univariate analysis, with independent risk factors subsequently identified using multivariate logistic regression analysis. Results. Univariate analysis revealed significantly higher proportions of males (35% vs. 20.2%, p = 0.003), alcohol consumption history (23.9% vs. 14.7%, p = 0.035), triglyceride (TG) (1.59 vs. 1.13 mmol/L, p 1.6 mmol/L, necessitating targeted intensive monitoring and clinical intervention.
How strong is the evidence?
Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 326 participants or records.
Read the paper
Related studies
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study
- Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.